CCR4 and primary cutaneous T-cell non-Hodgkin lymphoma: CCR4 could be used as a therapeutic target for cancer immunotherapy of several cancers, such as adult T-cell leukemia/lymphoma and cutaneous T-cell lymphomas (37).